INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AND BLOOD-TRANSFUSIONS ON THE COMPOSITION OF LYMPHOCYTE POPULATIONS IN HEMODIALYZED PATIENTS - COMMENTS

被引：0
|
作者：
WALSON, PD
机构：
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1995年 / 56卷 / 11期
关键词：
D O I：
10.1016/0011-393X(95)85129-1
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1201 / 1201
页数：1
相关论文
共 50 条
  • [41] POSITIVE EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON STATIC AND DYNAMIC PROPERTIES OF INDIVIDUAL RED-BLOOD-CELLS IN UREMIC HEMODIALYZED CHILDREN
    PAULITSCHKE, M
    MEIER, W
    LERCHE, D
    ZOELLNER, K
    SCHMIDT, G
    [J]. CLINICAL HEMORHEOLOGY, 1990, 10 (06): : 653 - 664
  • [42] Blood transfusions and human recombinant erythropoietin in premature newborn infants
    Williamson, P
    Griffiths, G
    Norfolk, D
    Levene, M
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1996, 75 (01): : F65 - F68
  • [43] INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON BLOOD-PRESSURE AND TISSUE RENIN-ANGIOTENSIN SYSTEMS
    EGGENA, P
    WILLSEY, P
    JAMGOTCHIAN, N
    TRUCKENBROD, L
    HU, MS
    BARRETT, JD
    EGGENA, MP
    CLEGG, K
    NAKHOUL, F
    LEE, DBN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05): : E642 - E646
  • [44] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
    TEFFERI, A
    SILVERSTEIN, MN
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 893 - 893
  • [45] TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH ALUMINUM OVERLOAD AND HYPERPARATHYROIDISM
    GRUTZMACHER, P
    EHMER, B
    LIMBACH, J
    MESSINGER, D
    KULBE, KD
    SCIGALLA, P
    [J]. BLOOD PURIFICATION, 1990, 8 (05) : 279 - 284
  • [46] PREOPERATIVE USE OF RECOMBINANT HUMAN ERYTHROPOIETIN FOR PREVENTION OF BLOOD TRANSFUSIONS IN PULMONARY TUBERCULOSIS PATIENTS
    Nikolaev, A. N.
    Demikhov, V. G.
    Dobin, V. L.
    Inyakova, N., V
    Skobin, V. B.
    Morshchakova, E. F.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : E115 - E115
  • [47] THE SAFETY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN AUTOLOGOUS BLOOD-DONORS
    GOODNOUGH, LT
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 124 (01): : 17 - 18
  • [48] RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN PATIENTS ON MAINTENANCE HOME HEMODIALYSIS
    PASCUAL, J
    LIANO, F
    MATESANZ, R
    TERUEL, JL
    ORTUNO, J
    [J]. NACHRICHTEN FUR DOKUMENTATION, 1991, 42 (05): : 343 - 343
  • [49] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HOSPITALIZATION OF HEMODIALYSIS-PATIENTS
    CHURCHILL, DN
    MUIRHEAD, N
    GOLDSTEIN, M
    POSEN, G
    FAY, WF
    BEECROFT, ML
    GORMAN, J
    TYLOR, DW
    [J]. CLINICAL NEPHROLOGY, 1995, 43 (03) : 184 - 188
  • [50] CHANGES IN THE KINETICS AND BIOPOTENCY OF LUTEINIZING-HORMONE IN HEMODIALYZED MEN DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    SCHAEFER, F
    VANKAICK, B
    VELDHUIS, JD
    STEIN, G
    SCHARER, K
    ROBERTSON, WR
    RITZ, E
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (05): : 1208 - 1215
12345